•  
  •  
  •  
  •  

2026-02-16 19:24:54

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Ind-Swift Laboratories allocates ₹40 Cr for Samba Facility Upgrade
  • LTM Partners with NFDC and Waves Bazaar to Host AI Cinema Showcase at India AI Impact Summit 2026
  • Arkade Developers registers Development Agreement for cluster redevelopment project with projected GDV of INR 700 crores
  • CIL's Capex on Solar at Rs.961 Crs till Jan FY'26 logs 2.33X growth
  • Siyaram Recycling Industries Ltd receives order worth Rs. 2.04 crore

Keywords Selected:  AkumsDrugsandPharmaceuticals

Stock Report

  • Akums delivers strong Q3 FY26 performance with 14.8% revenue growth and 21% Adj EBITDA growth
  • Akums introduces enhanced Gabapentin ER Formulation powered by RetenEx Technology for PHN Management
  • Akums Reports Q2 FY26 Results; Strengthens International Presence
  • Patent granted to Akums Drugs and Pharmaceuticals Limited
  • Akums Drugs and Pharmaceuticals Ltd signs framework agreement with Government of Zambia
  • IT search at Akums Drugs and Pharmaceuticals Limited
  • Akums Drugs and Pharmaceuticals Ltd enters into agreement for European Market
  • Akums Drugs and Pharmaceuticals Ltd enters into license and distribution agreement with Triple Hair Inc., Canada
  • Akums Drugs and Pharmaceuticals Ltd Launches Dual Action Heartburn Relief Chewable Tablet
  • Akums Appoints Shantanu R Chobhe as Corporate Quality Assurance Head

Latest Post

  • Ind-Swift Laboratories allocates ₹40 Cr for Samba Facility Upgrade
  • LTM Partners with NFDC and Waves Bazaar to Host AI Cinema Showcase at India AI Impact Summit 2026
  • Arkade Developers registers Development Agreement for cluster redevelopment project with projected GDV of INR 700 crores
  • CIL's Capex on Solar at Rs.961 Crs till Jan FY'26 logs 2.33X growth
  • Siyaram Recycling Industries Ltd receives order worth Rs. 2.04 crore


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025